Researchers investigate possible treatment de-escalation for tonsil cancer Monday, September 10, 2018 Dr. Scott Bratman, researcher at Princess Margaret Cancer Centre and CCTG Senior Investigator Wendy Parulekar awarded CIHR grant for HN.10 study The Canadian Institute of Health Research (CIHR) has announced a project grant award of $860,628 over six years for a research project lead by the Canadian Cancer Trials Group (CCTG). The HN.10 study will investigate the potential benefits of the de-escalation of treatment for patients with tonsil cancer. Oropharyngeal squamous cell carcinoma (OPSCC) is one of the most common forms of head and neck cancer. Although this type cancer is often associated with other risk factors, OPSCC related to human papillomavirus (HPV) infection has seen a dramatic increase globally. Read more >
